Aryballe, a Grenoble, France-based digital olfaction company, raised €7m in funding.
Tollys, a Lyon, France-based developer of TL-532, a synthetic specific agonist of Toll-like receptor 3 (TLR3) cancer immunotherapy, received over €1.5m ($1.6M) from Bpifrance as part of its deep tech financing program.
Sabio Group, a London, UK-based provider of contact centre solutions focused on helping businesses reduce costs whilst improving the customer experience, acquired Coverage Group, a Paris, France-based independent provider of customer experience and communications technology solutions.
inHEART, a Pessac, France-based provider of a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, closed a round of €3.7m.
MastOR, a Paris, France-based medical device company developing a surgical robot for laparoscopy assistance, raised €4.9m in funding.
GP Bullhound, a global technology advisory and investment firm, held the first close of its latest fund, at €125M.
Swile (FKA Lunchr), a Paris, France-based provider of an app for life at work, raised €70M in Series C funding.
ABC Transfer, a Tours, France-based industrial designer and manufacturer of secure Rapid Transfer Systems (RTS) for the biopharmaceutical industry, raised €3m ($3.2M) in series A financing round.
Ubble, a Paris, France-based biometric identification startup, raised €10m (approx. $11.3m) in funding.
ZE Energy, a Paris, France-based renewable energy producer, raised €4M in funding.
api.video, a Bordeaux, France-based PaaS which enables people to build, scale and operate on-demand and live videos in app, software or platform, raised $5.5m in seed funding.
Enterome SA, a Paris, France-based clinical-stage biopharmaceutical company leveraging its knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, raised €46.3m ($52.6m) in funding.
Jumbo Privacy, a Paris, France-based consumer privacy protection company, raised $8m in Series A funding.
Quortex, a Rennes, France-based provider of a video streaming solution over the Internet, raised €2.5m in seed funding.
DiogenX, a Marseille, France-based preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators for the treatment of type one diabetes (T1D), closed a seed financing round of €4.5m ($4.8M).